Metraipolis › archive › dc_21365cd52b1e
Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study — Europe PMC PMID:41131329
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41131329
- DOI
- 10.1038/s41433-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T02:48:20.268Z
- SHA-256 of the archived text
2f1c7bf6011b6a0459202772e22edfc40fde9a10c2ad061a96e0a12c98ea0f09- Stable URL of this page
https://metraipolis.com/documento/dc_21365cd52b1e
How to cite
Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study — Europe PMC PMID:41131329 — Europe PMC (en), https://europepmc.org/article/MED/41131329 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_21365cd52b1e (Metraipolis archive dc_21365cd52b1e, sha256 2f1c7bf6011b6a0459202772e22edfc40fde9a10c2ad061a96e0a12c98ea0f09)
BibTeX
@misc{dc21365cd52b1e,
title = {Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study — Europe PMC PMID:41131329},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41131329},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_21365cd52b1e; sha256 2f1c7bf6011b6a0459202772e22edfc40fde9a10c2ad061a96e0a12c98ea0f09},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41131329. Agents can read the archived copy with the MCP tool read_document.